Read in Spanish
An analysis conducted by researchers from the Faculty of Medicine at the University of Dalhousie, Canada concluded that of 146 patients who consumed benzodiazepines, 30% stopped using them after being prescribed medicinal cannabis.
Benzodiazepines are a class of drugs used in medicine for their sedative properties, which act in neurological conditions and anxiety. However, the study that has been published in the International Journal “Cannabis and Cannabinoid Research” was intended to seek alternatives due to the problematic side effects of these pills.
“After completing, on average, 2 months of medicinal cannabis prescription, 30.1% of patients discontinued benzodiazepines,” the study notes.
The analysis was mediated by means of statistical data that were rigorously analyzed each time the researchers prescribed the medicine. This information is part of the database of the Canabo Clinic, a clinic specialized in Canada on this type of medicine.
“In a post-prescription follow-up, 65 of the total patients (44.5%) stopped taking them. During the final follow-up, after 3 cannabis prescriptions, the number went up to 45.2% “
According to the study, 61% were women and of these, 54% said they had used cannabis before. The discontinuity of benzodiazepine use shows a stable dropout rate for an average of six months.
The descriptive statistics were used to quantify the proportion of the use of benzodiazepines over time in medicinal cannabis therapy.
Read the full study at this link: https://bit.ly/2Wj4xjC
Follow us on Instagram: @mcnglobal
7 minutos para aprender a hacer extractos de cannabis para uso terapéutico. Vía Mama Cultiva Argentina
Posted by Medical Cannabis News Costa Rica on Wednesday, August 16, 2017